Ascendis Pharma A/S (ASND)
240.50
-4.99
(-2.03%)
USD |
NASDAQ |
May 15, 16:00
240.63
+0.13
(+0.05%)
After-Hours: 20:00
Ascendis Pharma Market Cap : 14.86B for May 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Evaxion AS | 32.69M |
| Biodexa Pharmaceuticals Plc | 2.139M |
| Rhythm Pharmaceuticals, Inc. | 6.204B |
| IO Biotech, Inc. | 0.2446M |
| Amarin Corp. Plc | 303.84M |
Market Cap Related Metrics
| PE Ratio | 27.10 |
| PS Ratio | 14.78 |
| Price to Book Value | 26.43 |
| Price to Free Cash Flow | 293.81 |
| Price | 240.50 |
| Earnings Yield | 3.69% |
| Normalized PE Ratio | 27.10 |